Company filings profile · CIK 0001868279
ArriVent BioPharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for ArriVent BioPharma, Inc. (AVBP): 6 filings in the last 90 days vs 13 in the prior 90 (filing-velocity cooling ↓ · 0.46×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 13, 2026. Source-linked, daily-refreshed.
Material 8-K events — ArriVent BioPharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 13, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Oct 6, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 12, 2026 | Entry into a Material Agreement; Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 22, 2026 | Item 5.07 | ↗ |
| May 11, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| May 11, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 17, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 10, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch ArriVent BioPharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 13, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Oct 8, 2026 | SCHEDULE 13D/A | ↗ | |
| Oct 6, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 12, 2026 | 10-Q | 10-Q | ↗ |
| Aug 12, 2026 | 8-K | Entry into a Material Agreement; Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 27, 2026 | SCHEDULE 13G/A | ↗ | |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jun 22, 2026 | 8-K | Item 5.07 | ↗ |
| May 11, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| May 11, 2026 | 424B5 | 424B5 | ↗ |
| May 11, 2026 | 10-Q | 10-Q | ↗ |
| May 11, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Apr 28, 2026 | ARS | ARS | ↗ |
| Apr 28, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 28, 2026 | DEF 14A | FORM- DEF 14A | ↗ |
| Mar 17, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | S-8 | FORM S-8 | ↗ |
| Mar 5, 2026 | 10-K | 10-K | ↗ |
| Mar 5, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 4, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 4, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 4, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 4, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 4, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 3, 2026 | 4 | ↗ | |
| Jan 30, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 21, 2026 | SCHEDULE 13G | ↗ | |
| Nov 14, 2025 | SCHEDULE 13G/A | ↗ | |
| Nov 10, 2025 | 10-Q | 10-Q | ↗ |
| Nov 10, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 5, 2025 | SCHEDULE 13G/A | ↗ | |
| Oct 30, 2025 | SCHEDULE 13G | ↗ | |
| Oct 17, 2025 | SCHEDULE 13G/A | ↗ |